0.0414
+0.0002
+(0.49%)
As of 12:28:38 PM EST. Market Open.
Breakdown
TTM
Operating Cash Flow
-7,100,008.3230
Investing Cash Flow
28,210.0870
Financing Cash Flow
4,163,034.1730
End Cash Position
696,542.4580
Capital Expenditure
-21,025.9370
Issuance of Debt
5,443,140.5000
Repayment of Debt
-1,262,299.8270
Free Cash Flow
-7,121,034.2600
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
APLMW Apollomics, Inc.
0.0147
0.00%
SRZNW Surrozen, Inc.
0.0306
0.00%
LIXTW Lixte Biotechnology Holdings, Inc.
0.0497
0.00%
PTIXW Protagenic Therapeutics, Inc.
0.0045
0.00%
ENSCW Leisure Acquisition Corp.
0.0190
0.00%
NLSPW NLS Pharmaceutics AG
0.0120
+1.69%
DRMAW Dermata Therapeutics, Inc.
0.0244
+22.00%
KLTOW Klotho Neurosciences, Inc.
0.0347
+15.67%
REVBW Revelation Biosciences, Inc.
0.0155
-8.28%
ATNFW 180 Life Sciences Corp.
0.0097
-3.00%